CLAFORAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Claforan, and when can generic versions of Claforan launch?
Claforan is a drug marketed by Sanofi Aventis Us and Sterimax and is included in three NDAs.
The generic ingredient in CLAFORAN is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLAFORAN?
- What are the global sales for CLAFORAN?
- What is Average Wholesale Price for CLAFORAN?
Summary for CLAFORAN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 25 |
Clinical Trials: | 3 |
Patent Applications: | 6,949 |
DailyMed Link: | CLAFORAN at DailyMed |
Recent Clinical Trials for CLAFORAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
HÃ¥kan Hanberger | Phase 4 |
University Medical Center Groningen | Phase 4 |
University of California, San Francisco | Phase 1 |
US Patents and Regulatory Information for CLAFORAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | CLAFORAN | cefotaxime sodium | INJECTABLE;INJECTION | 062659-001 | Jan 13, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sterimax | CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER | cefotaxime sodium | INJECTABLE;INJECTION | 050596-002 | May 20, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sterimax | CLAFORAN | cefotaxime sodium | INJECTABLE;INJECTION | 050547-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sterimax | CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER | cefotaxime sodium | INJECTABLE;INJECTION | 050596-004 | May 20, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |